Navigation Links
'Scaffold' Could One Day Repair Damaged Hearts
Date:11/7/2008

It's the first to match structural, mechanical properties of heart tissue, scientists say

FRIDAY, Nov. 7 (HealthDay News) -- A biological scaffold that can help repair damaged hearts and could also be used to engineer other tissues has been developed by Massachusetts Institute of Technology researchers and colleagues.

The accordion-like, honeycomb scaffold is designed to be seeded with living heart cells or stem cells in order to treat congenital heart defects or aid the recovery of tissue damaged by a heart attack. As the scaffold is gradually absorbed into the body, it leaves behind new tissue, the researchers said.

The scaffold is the first specifically created to match the structural and mechanical properties of heart tissue, giving it a number of advantages over previous scaffolds designed for heart tissue engineering, according to the MIT team.

The general approach used in creating the heart scaffold has applications for other types of engineered tissues.

"In the long term, we'd like to have a whole library of scaffolds for different tissues in need of repair," Lisa E. Freed, a principal research scientist in the Harvard-MIT Division of Health Sciences and Technology, said in an MIT news release.

Each scaffold could be tailor-made with tissue-specific structural and mechanical properties, she said.

"We're already on the way to a few other examples," Freed said.

The research was published in the Nov. 2 online edition of the journal Nature Materials.

More information

The U.S. National Heart, Lung, and Blood Institute has more about cardiac rehabilitation.



-- Robert Preidt



SOURCE: Massachusetts Institute of Technology, news release, Nov. 2, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Pediatricians Could Help Screen for Alcohol Abuse in Home
2. Could It Be? A 100 Calorie Twinkie(R)?
3. Anti-VEGF drugs for retinal diseases could have serious side effects, scientists caution
4. Anti-VEGF Drugs for Retinal Diseases Could Have Serious Side Effects, Scientists Caution
5. Earlier Vaccination Could Cut Whooping Cough Deaths
6. Opt out system could solve donor organ shortage, says researcher
7. LegalView Reports on Rare Traumatic Brain Injury Condition That Could Cause Complete Paralysis of A Victim
8. End of Daylight Saving Time Could Be Heart-Wrenching
9. Flu Vaccine Could Prevent 357,000 Deaths in Pandemic
10. Researchers find new chemical key that could unlock hundreds of new antibiotics
11. Tests Could Predict Benefit From Cancer Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... Fort Worth, TX (PRWEB) , ... October 13, ... ... and financial planning agency serving communities in the greater Dallas, Miami, and Raleigh ... a young boy fighting to overcome a rare and deadly chromosome abnormality. , ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... certification process to promote standards of excellence for the field of eating disorders, ... March 22 – 25, 2018 in Orlando, Florida at the Omni Resort at ...
(Date:10/13/2017)... Calif. (PRWEB) , ... October 13, 2017 , ... Many ... dementia. However, many long-term care insurance companies have a waiver for care if the ... 90-day elimination period, when the family pays for care, is often waived, so the ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... be giving viewers the lowdown on sciatica in a new episode of "Success ... focuses on current events and innovation and investigates each subject in-depth with passion ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... , Sept. 25, 2017   Montrium ... Master File solutions, today—from the IQPC Trial Master ... , NL)—announced that EastHORN Clinical Services has ... clinical programs and TMF management. EastHORN, a leading ... eTMF platform to increase transparency to enable greater ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, ... complete response letter from the U.S. Food and Drug ... approval of sirukumab for the treatment of moderately to ... indicates additional clinical data are needed to further evaluate ... to severely active RA. ...
(Date:9/22/2017)... 2017 AVACEN Medical (AVACEN) announced that its ... helping those with the widespread pain associated with fibromyalgia ... in Essex, England commented, "I ... experiencing no sleep at all, tremendous pain, with every ... recommend [the AVACEN 100] enough, how this has and ...
Breaking Medicine Technology: